FDA
approval
· 2023-09-29
FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
Summary
The FDA approved a supplemental application for a generic fixed-dose combination tablet containing amlodipine, valsartan, and hydrochlorothiazide from Aurobindo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE (AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE)